Tag: Clinigen

March 27, 2019 Off

Clinigen’s Foscavir® gains approval for HHV-6 encephalitis in Japan

BURTON-UPON-TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that Foscavir (foscarnet sodium) has…

January 10, 2017 Off

Cumberland Pharmaceuticals to distribute Clinigen’s cancer treatment aid Totect in U.S.

By Dino Mustafić

Clinigen Group has made a deal with Cumberland Pharmaceuticals to market another product in the US, this time an oncology drug Totect (dexrazoxane hydrochloride).